Effect of Nisoldipine on Myocardial Ischemia: Evaluation by Holter Monitoring

  • S. Banai
  • S. Stern
  • D. Tzivoni
Conference paper


The effect of nisoldipine on myocardial ischemia during daily activity was studied in ten patients with chronic ischemic heart disease. There were nine males and one female, and their ages ranged from 50–76 years, mean of 63 years. All patients had a positive treadmill stress test, with and without angina pectoris, and had at least three ischemic episodes on a preliminary 24-h Holter monitoring.

Every patient performed 72-h Holter monitoring as a baseline study and a Bruce protocol exercise test at the end of these days of baseline monitoring. Nisoldipine therapy was then given (10 mg twice daily) for 3 days, after which the patients had another 3 days of Holter monitoring, and another exercise test was also performed.

During the control period 229 ischemic episodes were recorded in the ten patients, with variation between patients: 15–31 ischemic episodes per 72 h. The mean number of ischemic episodes per patient was 22.9.

The total duration of ischemia in the ten patients was 2918 min, with a wide range between patients (137–561 min). The mean ischemic duration per patient was 291.8 min.

During nisoldipine therapy the total number of ischemic episodes was reduced to 157 (P < 0.008), and the mean number of ischemic episodes per patient was reduced to 15.7. The total duration of ischemia was reduced to 1533 min (P < 0.006), and the mean duration of ischemia was reduced to 153.3 min. In nine patients both the number and the total duration of ischemia were markedly reduced. In one patient there was a slight increase in the number of ischemic episodes from 20 to 22 and in the duration of ischemia from 137 to 198 min. Of the 229 ischemic episodes observed during the control period, 194 (85%) were silent and 34 (15%) were symptomatic. There was a similar reduction in the number of silent and symptomatic episodes during nisoldipine therapy.

No significant changes were noted in all exercise parameters during the control period and during treatment with nisoldipine.

The preliminary results suggest that nisoldipine has a beneficial effect on spontaneous ischemic episodes occurring during daily activity.


Myocardial Ischemia Holter Monitoring Ischemic Episode Chronic Ischemic Heart Disease Antianginal Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Stern S, Tzivoni D (1974) Early detection of silent ischemic heart disease by 24 hour ECG monitoring of active subjects. Br Heart J 36: 481–486PubMedCrossRefGoogle Scholar
  2. 2.
    Wolf E, Tzivoni D, Stern S (1974) Comparison of exercise test and 24-hour ambulatory electrocardiographic monitoring in detection of ST-T changes. Br Heart J 90–95Google Scholar
  3. 3.
    Allen RD, Gettes LS, Phalan C, Avington ND (1976) Painless ST-segment depression in patients with angina pectoris. Chest 69: 467–473PubMedCrossRefGoogle Scholar
  4. 4.
    Schang SJ, Pepine CJ. Transient asymptomatic ST-segment depressing during daily activity. Am J Cardiol 39: 396–402Google Scholar
  5. 5.
    Tzivoni D, Gavish A, Benhorin J, Keren A, Stern S (1986) Myocardial ischemia during daily activities and stress. Am J Cardiol 58: 47B–50BPubMedCrossRefGoogle Scholar
  6. 6.
    Deanfield JE, Kenset W, Wilson RA et al. (1983) Silent myocardial ischemia due to mental stress. Lancet 2: 1001–1004Google Scholar
  7. 7.
    Stern S, Gavish A, Weizz G, Benhorin J, Tzivoni D (1986) Characteristics of silent and symptomatic myocardial ischemia during everyday activity. Circulation (Abstr) 74 (2): 57Google Scholar
  8. 8.
    Tzivoni D, Benhorin J, Gavish A, Stern S (1985) Holter recording during treadmill testing in assessing myocardial changes. Am J Cardiol 55: 1200–1203PubMedCrossRefGoogle Scholar
  9. 9.
    Cocco G, Strozzi C, Chu D et al. (1979) Therapeutic effects ofpindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. Eur J Cardiol 10: 59–69PubMedGoogle Scholar
  10. 10.
    Fazzini RF, Multino D, Zambaldi G (1985) Diltiazem in spontaneous angina: double blind cross over study with Holter monitoring. G Ital Cardiol 15: 1085–1089PubMedGoogle Scholar
  11. 11.
    Piccolo E, Cazzin R, Sartori F, Artusis L, Pascotto P (1982) Effects of oral calcium antagonists in spontaneous angina, verapamil and nifedipine in double blind cross over trial. G Ital Cardiol 12: 359–364PubMedGoogle Scholar
  12. 12.
    Oakley GDG, Fox KM, Dargie HJ et al. (1979) Objective assessment of treatment in severe angina. Br Med J 1: 1540PubMedCrossRefGoogle Scholar
  13. 13.
    Janis RA, Shrikhande AV, Greguski R, Pan M, Scriabine A (1987) Summary of binding studies with nisoldipine. (Abstr) First International Nisoldipine SymposiumGoogle Scholar
  14. 14.
    Godfraind T, Egleme C, Finet M, Janrnin P (1987) Comparison of nifedipine and nisoldipine on human coronary arteries and human cardiac tissue in vitro. (Abstr) First International Nisoldipine SymposiumGoogle Scholar
  15. 15.
    Bopp P, Divernois J, Noble J, Gabathuler J (1987) Acute hemodynamic effects of intravenous nisoldipine in patients with left ventricular failure. (Abstr) First International Nisoldipine SymposiumGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • S. Banai
  • S. Stern
  • D. Tzivoni

There are no affiliations available

Personalised recommendations